MECHANISMS OF AGEING AND DEVELOPMENT is a premier academic journal published by Elsevier Ireland Ltd, specializing in the fields of aging and developmental biology. With an impressive Q1 ranking in both categories as of 2023, this journal serves as a vital platform for researchers, professionals, and students seeking to advance their understanding of the complex biological processes that underlie aging and development. Since its inception in 1972, the journal has steadily contributed to the accumulation of valuable knowledge, maintaining a history of rigorous peer-reviewed articles that explore genetic, molecular, and cellular mechanisms impacting aging and development. Its high Scopus rankings—notably 5th in Aging and 8th in Developmental Biology—underscore its significance in the scientific community. While the journal follows a traditional publishing route without Open Access options, it remains an indispensable resource for those dedicated to the investigation of life’s aging processes and developmental phenomena. With publication projected through to 2024, the MECHANISMS OF AGEING AND DEVELOPMENT continues to shape the discourse within these critical research domains.

JOURNAL OF AGING AND PHYSICAL ACTIVITY is a premier academic journal dedicated to advancing the understanding of the multifaceted interactions between aging and physical activity. Published by Human Kinetics Publishers, this journal serves as a vital platform for researchers, practitioners, and students in geriatrics, gerontology, physical therapy, rehabilitation, and sports science. With an impact factor reflecting its influential contributions, the journal is classified in multiple categories, including Q2 rankings in both Physical Therapy, Sports Therapy and Rehabilitation and Rehabilitation. The scope of the journal spans from 1996 to 2024, encompassing a wealth of research that informs best practices and interdisciplinary collaborations on enhancing the quality of life for older adults. While the journal is not open access, it remains an essential resource for those committed to fostering healthier aging through evidence-based practices and innovative research.

BIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.

GeroScience, published by Springer, is an esteemed open-access journal that focuses on the multidisciplinary field of aging research. Since its inception in 2017, the journal has quickly established itself as a leader in its field, achieving impressive Q1 quartile rankings across various categories, including Aging, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, and Complementary and Alternative Medicine, as per 2023 evaluations. With a significant impact factor that underscores its influence and reach in academia, GeroScience aims to disseminate high-quality research that addresses the complex challenges and advancements related to aging. Its accessible publication format fosters greater dissemination of knowledge and encourages collaboration among researchers, practitioners, and students eager to contribute to the growing body of work on age-related health issues. As it continues to thrive, GeroScience remains a pivotal resource for anyone looking to stay at the forefront of aging research.

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

GERONTOLOGY, published by KARGER in Switzerland, is a prominent journal dedicated to the study and understanding of aging, with a keen focus on the interdisciplinary aspects of geriatric medicine and gerontology. Established in 1957, it has provided a platform for cutting-edge research that covers a wide range of topics including, but not limited to, the biological, psychological, and sociological aspects of aging. With an impressive ranking that places it in the Q3 category for Aging and Q2 for Geriatrics and Gerontology as of 2023, the journal continues to attract high-quality submissions from researchers worldwide, evidenced by its Scopus rankings, which position it favorably within relevant fields. While it operates under a subscription model, the journal remains committed to advancing knowledge that informs practice and policy within an aging society. By fostering innovative studies and discussions, GERONTOLOGY serves as an essential resource for researchers, health professionals, and students alike, dedicated to the care and understanding of older adults.

Welcome to the European Journal of Geriatrics and Gerontology, a peer-reviewed platform dedicated to advancing knowledge and research in the fields of geriatrics and gerontology. Published by GALENOS PUBL HOUSE, this journal serves as a critical resource for researchers, healthcare professionals, and students who are involved in the care, treatment, and study of elderly populations. Since its inception in 2019 and running through 2024, the journal aims to foster interdisciplinary collaboration and disseminate innovative research that addresses the unique challenges faced by older adults. With an ISSN of 2687-2625, the journal is classified in the Q4 quartile of the Geriatrics and Gerontology category, signifying its emerging influence within the academic community, despite its current Scopus ranking of #113 out of 116, reflecting a rich opportunity for growth and visibility. Although the journal is not open access, it maintains a commitment to scholarly rigor and quality. Engage with the European Journal of Geriatrics and Gerontology to contribute to and learn from the evolving discourse in aging research.

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.

Rejuvenation Research is a premier journal dedicated to the advancing field of gerontology and aging research, published by Mary Ann Liebert, Inc. Established in 2000, the journal serves as a pivotal platform for the dissemination of scholarly articles that explore the complex mechanisms of aging and innovative approaches to rejuvenation. With an impact factor reflective of its robust scholarly contributions, the journal currently holds a Q4 ranking in Aging and a Q3 ranking in Geriatrics and Gerontology, showcasing its relevance in the academic community. This periodic publication, welcoming open access submissions, invites researchers, professionals, and students alike to engage with cutting-edge findings that could shape future geriatric practices and enhance quality of life. The journal underscores the importance of interdisciplinary collaboration, encouraging explorations that intersect with biochemistry, genetics, and other vital areas of study. Through its ongoing commitment to high-quality research, Rejuvenation Research remains a critical resource for understanding the biological underpinnings of aging and the strategies to mitigate its effects.

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.